ketotifen has been researched along with Facial Dermatoses in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Facial Dermatoses: Skin diseases involving the FACE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazzatenta, C | 1 |
| Giorgino, G | 1 |
| Rubegni, P | 1 |
| de Aloe, G | 1 |
| Fimiani, M | 1 |
1 other study available for ketotifen and Facial Dermatoses
| Article | Year |
|---|---|
Solid persistent facial oedema (Morbihan's disease) following rosacea, successfully treated with isotretinoin and ketotifen.
Topics: Drug Therapy, Combination; Edema; Facial Dermatoses; Histamine H1 Antagonists; Humans; Isotretinoin; | 1997 |